InvestorsHub Logo

dlcullum

06/09/16 11:49 AM

#204125 RE: Bngo #204091

I think that's the issue - if the fda gives Sequestox the same approval as PFE's drug (I.e., adt labeling for iv and nasal but not oral), it's not going to help us - we need all 3 adt labels (iv nasal oral) to be profitable.

Right?

Couch

06/09/16 1:53 PM

#204172 RE: Bngo #204091

You nailed it!

The FDA is going to approve ELI 200 - and if that Pfizer approval - it saved Elite 40-50 million dollars!!

PLUS - as you know - Pfizer will pave the way for the ADT pharmacologic approach to opioids.